Clinical Trial Update: 68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating 68Ga-DOTATATE PET imaging in patients with neuroendocrine tumors to assess diagnostic performance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor
• Islet Cell Tumor
• Neuroendocrine Carcinoma
• Neuroendocrine Tumor
• Pancreatic Neuroendocrine Tumor

Snippet

Sponsor: Ochsner Health System | Conditions: Neuroendocrine, Neuroendocrine Tumor | Phase 1, Phase 2 | Status: UNKNOWN